Login / Signup

Outcomes Associated With Resuming Direct Oral Anticoagulant Therapy Following Admission for a Gastrointestinal Bleed.

Sara M ValanejadKyle A DavisSarah Anne Nisly
Published in: The Annals of pharmacotherapy (2020)
Resuming anticoagulation within 7 days of admission for an index GIB was not associated with a recurrent GIB within 90 days of discharge.
Keyphrases
  • atrial fibrillation
  • venous thromboembolism
  • emergency department
  • stem cells
  • mesenchymal stem cells
  • skeletal muscle
  • weight loss